Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2919 (LINC02919) is a member of the lincRNA subclass of long non-coding RNAs. LincRNAs are autonomously transcribed RNA molecules, typically over 200 nucleotides, that do not overlap known coding sequences. They are distinguished from other non-coding RNAs by their intergenic location and generally non-coding nature, although some may contain small open reading frames. LincRNAs are implicated in a variety of cellular functions, primarily through modulation of chromatin structure, regulation of transcription, and as scaffolds for protein complexes involved in gene regulation. Their expression is frequently tissue-specific and dynamically regulated, and some have been associated with specific diseases. However, for LINC02919 specifically, no experimentally validated function, disease association, or pharmacological targeting has been reported in the provided sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2919 (LINC02919).